ANAHEIM, CA--(Marketwired - November 03, 2016) - LiveWire Ergogenics, Inc. (OTC PINK: LVVV) a performance nutrition product development and marketing company, announced today that it has signed a strategic consulting and marketing agreement with EquiNet, LLC, to provide market research, financial analysis and corporate consulting services for LiveWire.
EquiNet will provide comprehensive consulting services to LiveWire, beginning with management interviews and conducting an in-depth analysis of the company's current business model, financial and equity structure to establish a detailed "Roadmap to Success Doctrine".
EquiNet will identify and establish a schedule for upcoming LiveWire milestone events, will coordinate press releases and other relevant publications. EquiNet will use its considerable outreach via its established subscriber base and social media outreach to present the company and its business model to a wider clientele, to achieve better market penetration.
EquiNet will also take over direct investor communication, conduct acquisition research and utilize its longstanding financial industry relationships to review debt structure, debt holders, analyze current market-makers and set timelines for financial reporting.
"I'm looking forward to having EquiNet's experienced team dig into LiveWire and extract the true value of the company. LiveWire has several thousand customers that have enjoyed the benefits of LiveWire Energy chews over the last 8 years, and we will continue to provide access to our great product for years to come," states Bill Hodson, CEO of LiveWire Ergogenics.
"I believe it's crucial for LiveWire to implement an improved strategy to better communicate the near, and long-term goals of the company. This will allow us, together with EquiNet's team and affiliates, to expand and maintain a well-informed investor base. We strongly believe, as LiveWire implements recommendations from EquiNet, this will improve our market presence and our goal to improve shareholder value," added Hodson.
About LiveWire Ergogenics, Inc: LiveWire Ergogenics, Inc. (LVVV) markets value added nutritional dietary supplements in the form of a soft chew, targeting the amateur and professional athletics community, the health conscience consumer, and participants in today's active lifestyle culture. For more information visit: www.livewireenergy.com.
About EquiNet: EquiNet is an information marketing and corporate consulting firm that provides comprehensive and best-in-class consulting services and financial market research to small and middle market emerging growth companies. EquiNet offers its clients a unique combination of strategic counsel, assistance with capital formation and secondary market support. EquiNet utilizes longstanding personal relationships in the financial industry, drawing from a proprietary, high-quality and highly focused data base of financial institutions and investors and has a broad outreach on the social networks most used by most investors today. As a result, EquiNet clients can expect to achieve improved market awareness, a greater fair market value for their stock, create the conditions to raise required working capital at more favorable conditions and produce satisfactory value for its shareholder base over time. For more information visit www.equinet.us.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.